Nature’s Bioceuticals Commencing Production of Its Breathing Relief Formula

We are also finalizing our new product labeling and packaging, which we feel provides the proper image for our company and products.

Nov 9 2011 --- Nature’s Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. announced that it is finalizing arrangements to commence production of its Breathing Relief Formula. This is the formula that the company has previously referred to as its COPD formula, which will now be marketed as a dietary supplement under the Dietary Supplement Health and Education Act of 1994 (DSHEA), thus requiring a name change.

Robert deZanger, CEO of Natures Bioceuticals stated “ I am extremely satisfied that our new strategy allows us to market this product as a supplement immediately, instead of waiting many years and spending hundreds of millions of dollars seeking FDA approval as a drug.

We have begun placing orders for the natural ingredients, bottles, etc. and expect to have product inventory ready for sale within 30 to 60 days. We are also finalizing our new product labeling and packaging, which we feel provides the proper image for our company and products. We anticipate sales in excess of $10,000,000.00 the first year and then expanding and exponentially thereafter.”